Inovio Pharmaceuticals, Inc. (INO)
1.105
-0.04
(-3.91%)
USD |
NASDAQ |
Oct 12, 16:00
1.14
+0.04
(+3.17%)
After-Hours: 04:46
Inovio Pharmaceuticals Free Cash Flow (Quarterly) : -18.05M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.05M |
| March 31, 2026 | -21.59M |
| December 31, 2025 | -19.50M |
| September 30, 2025 | -21.64M |
| June 30, 2025 | -20.84M |
| March 31, 2025 | -26.93M |
| December 31, 2024 | -19.66M |
| September 30, 2024 | -27.44M |
| June 30, 2024 | -28.66M |
| March 31, 2024 | -28.80M |
| December 31, 2023 | -26.28M |
| September 30, 2023 | -29.11M |
| June 30, 2023 | -32.34M |
| March 31, 2023 | -36.96M |
| December 31, 2022 | -36.51M |
| September 30, 2022 | -67.55M |
| June 30, 2022 | -51.25M |
| March 31, 2022 | -61.88M |
| December 31, 2021 | -38.53M |
| September 30, 2021 | -46.66M |
| June 30, 2021 | -78.67M |
| March 31, 2021 | -53.08M |
| December 31, 2020 | -52.18M |
| September 30, 2020 | -74.54M |
| June 30, 2020 | -27.19M |
| Date | Value |
|---|---|
| March 31, 2020 | -25.59M |
| December 31, 2019 | -13.85M |
| September 30, 2019 | -27.87M |
| June 30, 2019 | -24.01M |
| March 31, 2019 | -33.11M |
| December 31, 2018 | -17.62M |
| September 30, 2018 | -24.80M |
| June 30, 2018 | -19.48M |
| March 31, 2018 | -13.73M |
| December 31, 2017 | -14.83M |
| September 30, 2017 | -20.90M |
| June 30, 2017 | -21.76M |
| March 31, 2017 | -16.02M |
| December 31, 2016 | -14.97M |
| September 30, 2016 | -19.12M |
| June 30, 2016 | -15.99M |
| March 31, 2016 | -16.42M |
| December 31, 2015 | -7.600M |
| September 30, 2015 | 14.64M |
| June 30, 2015 | -9.668M |
| March 31, 2015 | -12.60M |
| December 31, 2014 | -8.347M |
| September 30, 2014 | -8.364M |
| June 30, 2014 | -8.854M |
| March 31, 2014 | -5.739M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Nektar Therapeutics | -75.86M |
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Fortress Biotech, Inc. | -59.36M |
| Tonix Pharmaceuticals Holding Corp. | -42.44M |
| Kura Oncology, Inc. | -63.20M |